Portal de Periódicos da CAPES

Histamine and asthma: an appraisal based on specific H 1 ‐receptor antagonism

1990; Wiley; Volume: 20; Issue: s2 Linguagem: Inglês

10.1111/j.1365-2222.1990.tb02459.x

1365-2222

Peter Howarth,

Allergic Rhinitis and Sensitization

Clinical & Experimental AllergyVolume 20, Issue s2 p. 31-41 Histamine and asthma: an appraisal based on specific H1-receptor antagonism P. H. HOWARTH, Corresponding Author P. H. HOWARTH Immunopharmacology Group, Medicine I, Southampton General Hospital. Southampton, U.K.Dr P. H. Howarth. Immunopharmacology Group. Medicine 1. Level D. Centre Block. Southampton General Hospital Southampton SO9 4XY, U.K.Search for more papers by this author P. H. HOWARTH, Corresponding Author P. H. HOWARTH Immunopharmacology Group, Medicine I, Southampton General Hospital. Southampton, U.K.Dr P. H. Howarth. Immunopharmacology Group. Medicine 1. Level D. Centre Block. Southampton General Hospital Southampton SO9 4XY, U.K.Search for more papers by this author First published: August 1990 https://doi.org/10.1111/j.1365-2222.1990.tb02459.xCitations: 34AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Fourneau, E, Bovet, D. Recherches sur ľaction sympathicolytique ďun nouveau derive du dioxane. Arch Int Pharmacodyn Therap 1933; 46: 178– 191. 2 Loew, ER. Pharmacology of antihistamine compounds, Physiol Rev 1947; 7: 542– 573. 3 Pandit, PR, Kulkarni, SD, Jogleker, AY. Study on the relationship between antihislamine, anticholinergic and central depressant properties of various antihistamines. Indian J Med Sci 1973; 27: 920– 929. 4 Casterline, CL, Evans, R. Further studies on the mechanism of human hislamine-induccd asthma. J Allergy Clin Immunol 1977: 59: 420– 424. 5 Byck, R. Drugs and the treatment of psychiatric disorders; In: Gilman Goodman, eds. The pharmacological basis of therapeutics. New York : Macmillan, 5th edn 1975; 152– 200. 6 Stone, CA, Wenger, HC, Luddcn, CT, Slavorkski, JM, Russ, CA. Antiserothonin-anlihistaminic properties of cyproheptadine. J Pharmacol Exp Ther 1961; 131: 73– 84. 7 Mota, I, Da Silva, WD. The anti-anaphytactic and histamine releasing properties of the antihistamines. The effect on the mast cell. Br J Pharmacol 1960; 1: 396– 404. 8 Church, MK. Gradidge, CF. Inhibition of histamine releases from human lung in vitro by antihistamines and related drugs. Br J Pharmac 1980; 69: 663– 667. 9 Arunlakshana, O. Histamine release by antihistamines. J Physiol 1953; 1 19: 47– 48P. 10 Lichcnstein, LM. Gillespie, E. The effects of H1 and H2 antihistamines on allergic histamine release and its inhibition b histamine. J Pharmac Exp Thcr 1975, 192: 441– 450. 11 Rafferty, P. Holgale, ST. Terfenadine (Seldane) is a potent and selective histamine H1-receptor antagonist in asthmatic airways. Am Rev Resp Dis 1987; 135: 181– 184. 12 Van Wawe, J. Awoulers, F. Niemegeers, CJ, Janssen, F, Van Nueten, JM, Janssen, PAJ. In vivo pharmacology of Aslemizole, a new type of H1-antihistamine compound H1. Arch Int Pharmacodyn Ther 1981; 251: 39– 51. 13 Nicholson, AN, Smith, PA. Spencer, MB. Antihistamines and visual function: studies on dynamic activity and the pupillary response to light. Br J Clin Pharmaco 1982; 14: 683– 690. 14 Clissold, SP, Sorkin, EN. Goa, KL. Loraladine. A preliminary review of its pharmacodynamic properties and therapeutic efficacy. Drugs 1989; 37: 45– 57. 15 De Vos, C. Cetirizine: animal pharmacology and toxicology. Allergy Forum. Prof. Postgrad Services Ltd, 1988: 4– 6. 16 Bousquet, J, Lebelle, B, Chanal, I. Morell, A, Michel, FB. Antiallergic activity of Loraladine and Terfenadine assessed by nasal challenge. J Allergy Clin Immunol 1988: 81: 228. 17 Fadel, R. Herpin-Richurd, N. Rihoux, J-P, Hennocq, E. Inhibitory effect of cetirizine 2HC1 on eosinophil migration in vivo. Clin Allergy 1987; 17: 373– 379. 18 Windaus, A, Vogt, W. Synthcse des iminazolyethyamins. Ber Deutsch Chem Ges 1907; 40: 369. 19 Dale, HH. Laidlaw, PP. Histamine shock. J Physiol 1919; 52: 355– 390. 20 Weiss, S, Robb, G, Blumgart, HL. The velocity of blood flow in health and disease as measured by the effect of histamine on the minute vessels. Am Heart J 1929; 4: 664– 691. 21 Weiss, S, Robb, GP, Ellis, LB. The systemic effects of histamine in man. Arch Int Med 1932: 49: 360– 396. 22 Curry, JJ. The action of histamine on the respiratory tract in normal and asthmatic subjects, J Clin Invest 1946; 25: 785– 794. 23 Boushey, HA, Hollzman, J, Sheller, JR, Nadel, JA. Bronchial hyperreactivity. Am Rev Resp Dis 1980; 121: 389– 413. 24 Staub, AM, Bovet, D. Action de la Thymoxyethyldiethylamine (929F) et des ethers phenoliques sur le choc anaphylactique. Compt Rend Soc Biol 1937; 125: 818– 821. 25 Schid, HO, Hawkins, DS, Mongar, JL, Herxheimer, H. Reactions of isolated human asthmatic lung and bronchial tissue to a specific antigen. Histamine release and muscular contraction. Lancet 1951; ii; 376– 382. 26 Riley, JS. Histamine in tissue mast cells. Science 1953; 118: 332– 333. 27 Graham, HT. Lowry, OH, Wheelwright, F, Lenz, NA, Parish, HH. Distribution of histamine among leucocytes and platelets. Blood 1955; 10: 467– 481. 28 Ishizaka, K, Ishizaka, T. Terry, WD. Antigcnic structure of E globulin and rcagenic antibody. J Immunol 1967; 99: 849– 858. 29 Johansson, SGO. Raised levels of a new immunoglobulin class (19ND) in asthma. Lancet 1967; ii: 95l– 953. 30 Tomioka, H, Ishizaka, K. Mechanisms of passive sensitization. II. Presence of receptors for Ige on monkey mast cells. J Immunol 1971; 107: 971– 978. 31 Agius, RM, Howarth, PH. Robinson, C. Holgate, ST Human bronchoalveolar mast cells and their mediators. In: AB Kay (ed). Asthma; Clinical Pharmacology and Therapeutic Progress. Oxford ; Blackwell Scientific, 1986; 274– 285. 32 Tomioka, M, Ida, S, Yariko, S, Ishikara, T, Takishima, T. Mast cells in bronchoalveolar lumen of patients with bronchial asthma. Am Rev Resp Dis 1984; 129: 1000– 1005. 33 Kirby, JG, Hargreave, FE, Gleich, GJ. O'Byrne, PM. Bronchoalveolar cells profiles of asthmatic and non-asthmatic subjects. Am Rev Resp Dis 1987; 136: 379– 383. 34 Flint, KC, Leung, KBV. Hudspith, BN. Brostoff, J. Pearce, FL, McJohnson, N. Bronchoatveolar mast cells in extrinsic asthma: a mechanism for the initiation of antigen specific bronchoconstriction. Br Med J 1985: 291: 923– 926. 35 Gravelyn, TR, Pan, PM. Eschenbacher, Wl. Mediator release in an isolated airway segment in subjects willi asthma. Am Rev Resp Dis 1988; 137: 641– 646. 36 Zehr, B. Casele, T, Wood, D, Monick, M, Flossinger, C, Richerson, H. Hunninghake, G. Segmental airway lavage increases detection of mediators in airways of normal individuals, individuals with allergic rhinitis and allergic asthma. Am Rev Resp Dis 1989; 137: 211. 37 Wenzel, SE, Fowler, AA, Swartz, LB. Activation of pulmonary mast cells by bronchoalveolar allergen challenge: in vivo release of histamine and tryptase in atopic subjects with and without asthma. Am Rev Resp Dis 1988; 137: 1002– 1008. 38 Simon, RA. Stevenson, DD, Arroyave, CM, Tan, EN. The relationship of plasma histamine to the activity of bronchial asthma. J Allergy Clin Immunol 1977; 60: 312– 316. 39 Barnes, PJ. Ind, PW, Brown, MJ. Plasma histamine and catecholamines in stable asthmatic subjects. Clin Sci 1982; 62: 661– 665. 40 Howarth, PH, Durham, SR, Kay, AB, Holgale, ST. The relationship between mast cell-mediator release and bronchial reactivity in allergic asthma. J Allergy Clin Immunol 1987; 80: 703– 711. 41 Beasley, R, Roche, WR, Roberts, JA, Holgate, ST. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Resp Dis 1989; 139: 806– 817. 42 Bruce, C, Weatherstone, R. Seaton, A. Taylor, WH. Histamine levels in plasma, blood and urine in severe asthma, and the effect of corticosteroid treatment. Thorax 1976: 31: 724– 729. 43 Durham, SR, Lee, TH. Cromwell, O, Shaw, RJ, Merrett, TG, Merrett, J, Cooper, P. Kay, AB. Immunological studies of antigen-induced late asthmatic reactions. J Allergy Clin Immunol 1984: 74: 49– 60. 44 Lee, TH, Brown, MJ. Nagy, L, Causon, R, Walport, MJ, Kay, AB. Exercise-induced release of histamine and neutrophil chemotactic activity in atopic asthmatics. J Allergy Clin Immunol 1982: 70: 73– 81. 45 Hegardt, B, Lowhagen, O, Svedmyr, N, Granerus, G. The protective property of equipotent bronchodilating doses of inhaled KWD2I3I and terbutaline against allergen-induced bronchospasm. Allergy 1982: 37: 407– 416. 46 Moodley, I. Morgan, DJR, Davies, RJ. The measurement of histamine during allergen-induced asthma. Clin Sci 1983; 64: 12. 47 Howarth, PH, Pao, GJ-K, Church, MK, Holgate, ST. Exercise and isocapnic hyperventilation-induced bronchoconstriction in asthma: relevance of circulating basophils to measurement of plasma histamine. J Allergy Clin Immunol 1984: 73: 391– 399. 48 Ind, PW, Brown, MJ, Lhoste, LJM, Macquin, I. Dollery, CT. Determination of hislamine and its metabolites. Concentration effect relationships of infused histamine in normal volunteers. Agents Actions 1982; 12: 12– 16. 49 Ishizaka, T. De Bernardo, R. Tomioka, H, Lichtenstein, LM. Ishizaka, K. Identification of the basophil granulocyte as a site of allergic hislamine release. J Immunol 1972: 108: 1000– 1008. 50 Murray, JJ. Tonnel, AB, Brash, AR, Roberts, LJ, Gosset, P, Workman, R. Capron, A, Oates, JA. Release of prostaglandin D2 into human airways during acute antigen challenge. New Engl J Medicine 1988; 315: 800– 804. 51 Dworski, R, Fitzgerald, GA. Roberts, LJ, Gates, JA, Schwartz, L.B, Sheller, JR. Eicosanoid formation in atopic human lung: effect of Indomethian. Am Rev Resp Dis 1988: 137: 375a. 52 Metzger, WJ, Zavala, D, Richerson, HB. Local allergen challenge and bronchoalveolar lavage of allergic asthmatic lungs; description of the model and local airway inflammation. Am Rev Resp Dis 1987; 135: 433– 440. 53 Majno, G, Gilmore, V. Leventhal, M. On the mechanism of vascular leakage caused by histamine-type mediators. Circ Res 1967: 21: 833– 847. 54 Clark, RA, Gallin, J, Kalpan, AP. The selective eosinophil chemotactic activity of histamine J Exp Med 1975; 142: 1462– 1476. 55 Turnbull, L.W., Kay, A.B. Eosinophils and mediators of anaphylaxis. Histamine and imidazole acetic acid on chemotactic agents for human eosinophil leucocytes. Immunology 1976; 31: 797– 802. 56 Shelhamer, JH, Marom, Z, Kalincr, M. Immunologic and neuropharmacologic stimulation of mucous glycoprolein release from human airways in vitro. J Clin Invest 1980: 66: 1400– 1408. 57 Platshon, L, Kalincr, M. The effect of the immunologic release of histamine upon human lung cyclic nucleotide levels and prostaglandin generation. J Clin Invest 1978: 62: 1113– 1121. 58 Herxheimer, H. Antihistamines in bronchial asthma. Br Med J 1949; II: 901– 905. 59 Nogrady, SG. Bevan, C. Inhaled antihistamines-bronchodilatation and effects on histamine and methacholine-induced bronchoconstriction. Thorax 1978; 33: 700– 704. 60 Groggins, RC. Milner, AD, Stokes, GN. The bronchodilator effects of chlorpheniramine in childhood asthma. Br J Dis Chest 1979: 73: 297– 301. 61 Popa, VT. Effect of an H1 blocker, chlorpheniramine, on inhalation tests with histamine and allergen in allergic asthma. Chest 1980: 78: 442– 451. 62 Partridge, MR, Saunders, KB. Effect of an inhaled antihistamine (clemastine) as a bronchodilalor and as a maintenance treatment in asthma. Thorax 1979; 34: 771– 776. 63 Phillips, MJ, Ollier, S. Gould, C, Davies, RJ. Effect of antihistamines and antiallergic drugs on responses to allergen and histamine provocation tests in asthma. Thorax 1984; 39: 345– 351. 64 White, J, Eiser, NM. The role of histamine and its receptors in the pathogenesis of asthma. Br J Dis Chest 1983; 77: 215– 226. 65 Howarth, PH. The influence of astemizole in asthma; effect on histamine and methacholine-induced broncho constriction. Br J Clin Pharmac in press. 66 Patel, ER. Effect of terfenadine on methacholine-induced bronchoconstriction in asthma. J Allergy Clin Immunol 1987; 79: 355– 358. 67 Finnerty, JP, Holgate, ST. Role of histamine and prosta-glandins in EIA. J Allergy Clin Immunology 1988; 81: 240. 68 Brik, A, Tashkin, DP, Gong, H, Dauphinee, B, Lee, E. Effect of cetirizine, a new histamine antagonist, on airway dynamics and responsiveness to inhaled asthma in mild asthma. J Allergy Clin Immunol 1987; 80: 51– 56. 69 Kemp, JP, Metzer, EO, Orgel, HA. A dose response study of the bronchodilator action of azelastine in asthma. J Allergy Clin Immunol 1987; 79: 893– 899. 70 Storms, W, Middlcton, E, Dvorin, D. Azelastine in the treatment of asthma. J Allergy Clin Immunol 1985; 75: 167. 71 Taytard, A, Beaumont, D, Pujet, JC, Sapene, M, Lewis, PJ. Trcatment of bronchial asthma with terfenadine; a randomised controlled trial. Br J Clin Pharmac 1987; 24: 743– 746. 72 Gould, CAL, Ollier, S, Aurich, R, Davies, RJ. A sludy of the clinical efficacy of azelastine in patients with extrinsic asthma, and its effect on airway responsiveness. Br J Clin Pharmac 1988; 26: 515– 525. 73 Anderson, SD. Current concepts of exercise-induced asthma. Allergy 1983; 38: 289– 302. 74 Egglestone, PA, Kagey-Sabokta, A, Schleimer, RP, Lichtenstein, LM. Interaction between hypersomolar and IgE mediated histamine release from basophils and mast cells. Am Rev Resp Dis 1984; 130: 86– 91. 75 Curzen, N. Raffcrty, P. Holgate, ST. Effect ol a cyclooxygenase inhibitor, flurbiprofen and an H1-antihistamine receptor antagonist, terfenadine atone and in combination on allergen-induced immediate bronchoconstriction in man. Thorax 1987: 42: 946– 952. 76 Holgate, ST, Finnerty, JP. Antihistamine in asthma. J Allergy Clin Immunology 1989; 83: 537– 547. 77 Hardy, CC. Robinson, C. Tattersfield, AE, Holgate, ST. The bronchoconstrictor effect of inhaled Prostaglandin D2 in normal and asthmatic man. N Engl J Med 1984; 311: 209– 213. 78 Beasley, CRW, Robinson, C, Featherstone, RL. 9,11PGF2 and PGF2, a novel metabolite of prostaglandin D2 is a potent contractile agonist of human and guinea-pig airways. J Clin Invest 1987; 79: 978– 983. 79 Naclerio, RM, Proud, D. Togias, AG. Inflammatory mediators in late antigen-induced rhinitis. N Eng J Med 1985; 313: 65– 70. 80 Djukanovic, R. Mann, M, Rimmer, J, Powers, A. Howarth, PH. The influence of allergen inhalation on basophil function in atopic asthma. Clin Exp Allergy in press. 81 Rafferty, P, Jackson, L, Smith, R. Holgale, ST. Terfenadine in the treatment of grass pollen sensitive asthmatics during the hay fever season. Br J Ciin. Pharmacol 1988; 25; 623– 624. 82 Mann, JS, Cushley, MJ, Holgate, ST. Effect of vagal blockade on adenosine-induced bronchoconstriction in asthma. Thorax 1984; 39: 230– 231. 83 De Monchy, JGR, Kauflfman, HF. Venge, P. Koeter, GH. Jansen, HM, Sluiter, HJ, DeVries, K. Bronchoalvcolar-lavage eosinophilia during allergen-induced late asthmatic reaction. Am Rev Resp Dis 1985; 131: 373– 376. 84 Capron, A, Dessaint, J-P, Tonnel, AB. IgE receptors on inflammatory cells. In: FB Bousquet. P Goddard, eds. Highlights in asthmology. Berlin . Spnnger-Verlag, 1987: 107– 116. Citing Literature Volume20, Issues2August 1990Pages 31-41 ReferencesRelatedInformation